Distephar SRL
1.9 FTEDistephar reported total assets of €1.01m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026), with 1.9 full-time equivalent.
The score of Distephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +17 % Total assets +9 % Headcount (avg FTE) +6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Distephar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 67,795 € | ||||
| Equity | 223,444 € | ||||
| Cash | 126,010 € | ||||
| EBITDA | 134,414 € | ||||
| Total assets | €1.01m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 08 Aug 2022
Distephar's financial analysis
- Solvency22.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Distephar
Distephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0885.857.745
- VAT number
- BE0885857745
- Peppol
- Registered · 0208:0885857745 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Dec 2006
- Registered office
- 8210 Zedelgem
- Size
- Micro · 1.9 FTE
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Distephar (SRL) has been based in Zedelgem since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 67,795 € and equity of 223,444 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 22.2%, below the median of its sector (44.2%).
Companies similar to Distephar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Duwez Retail sale of pharmaceutical products Namur · balance sheet €1.01m
- Apotheek Pede Retail sale of pharmaceutical products Dilbeek · balance sheet €1.00m
- Wezefarma Retail sale of pharmaceutical products Rotselaar · balance sheet €1.01m
- Digitale Pharma Retail sale of pharmaceutical products Bernissart · balance sheet €1.00m
- Smeets TOM Retail sale of pharmaceutical products Lint · balance sheet €1.01m
- Linden Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 998,099 €
- Pharm TG Retail sale of pharmaceutical products Sambreville · balance sheet €1.01m
- Pharmacies de l'Ourthe Retail sale of pharmaceutical products Somme-Leuze · balance sheet 994,832 €
Frequently asked questions about Distephar
What is the revenue of Distephar?
Distephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Distephar?
In Belgium, the VAT number is the company number prefixed with BE: BE0885857745 for Distephar, if the company is VAT-registered. Its company number (CBE) is 0885.857.745.
Where is the registered office of Distephar?
According to the CBE register, the registered office of Distephar is in 8210 Zedelgem.
What is the equity of Distephar?
At the close of the 2025 financial year, the equity of Distephar amounts to 223,444 €, a solvency of 22.2% of total assets.
How many people work at Distephar?
1.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Distephar?
The register lists 4 active mandates at Distephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Distephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →